Qianjiang Yongan Pharmaceutical Co., Ltd.

¥12.09As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002365Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.30%)
Div yield 0.83%
ROE 5.11%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM 31.37
TSR TTM (29.56%)
Mkt cap ¥3.496B
ROIC 9.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
24.41%
168.94%
Hold 9|8|11|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.20
0.20
0.22
8.19%
21.80%
11.42%
20.24%
Revenue¥M
251.1
246.4
242.7
248.5
15.88%
9.46%
3.95%
3.45%
Peers (US$524.0M)
Cap (US$)
PE
529.0M
169.8x
Capital
TTM
5Y
10Y
Leveragex
3.118
(1.185)
(0.873)
EBIT/Intx
1.181
1.248
1.370
Own earn%
150.84
144.50
120.01
Sh yield%
23.28
42.47
43.51
Owners
Insiders/Inst%
13.43
71.76
Short interest%
5.36
SBC / revenue%
5.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
1–6
$1 testx
—
Incr. ROIC%
1